Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Participants in the Diabetes Prevention Program (DPP) randomized to intensive lifestyle modification (ILS) or metformin had a significantly reduced incidence of diabetes compared with those randomized to placebo, yet most were still at risk because they had pre-diabetes. We explored the effect of baseline characteristics, weight change, ILS, and metformin on regression from pre-diabetes to the lowest-risk state of normal glucose regulation (NGR) defined by American Diabetes Association criteria. RESEARCH DESIGN AND METHODS: The DPP was a prospective randomized trial. Cox proportional hazards modeling was used to identify predictors of regression from pre-diabetes to NGR over 3 years of follow-up. RESULTS: Lower baseline fasting (hazard ratio 1.52, P < 0.01) and 2-h (1.24, P < 0.01) glucose predicted regression to NGR, as did younger age (1.07, P < 0.01) and greater insulin secretion (1.09, P = 0.04). ILS (2.05, P < 0.01) and weight loss (1.34, P < 0.01) had significant and independent effects on regression. A nonsignificant trend for regression was also observed for metformin (1.25, P = 0.06), male sex (1.17, P = 0.08), and insulin sensitivity (1.07, P = 0.09). In those entering the study with both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), male sex and insulin sensitivity predicted regression to isolated IFG, whereas ILS, metformin, female sex, and greater insulin secretion predicted regression to isolated IGT. CONCLUSIONS: Insulin secretion, and other biologic processes retained with younger age, are key in restoring NGR in people with pre-diabetes. However, NGR may also be attained through weight loss and additional aspects of ILS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the Diabetes Prevention Program (DPP), greater baseline β-cell function and insulin sensitivity contributed independently to the restoration of NGT following lifestyle changes ( 65 , 66 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [66]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“ILS and metformin both have been shown to be effective strategies for diabetes prevention, but in the DPP only ILS restored NGR significantly more frequently than did placebo (2).”
BackgroundTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 3×
“A number of clinical trials have demonstrated the effectiveness of lifestyle and/or drug therapy at preventing diabetes in people with pre-diabetes (2; 4-9), but none have examined the effectiveness of an intervention on returning those with pre-diabetes to NGR.”
BackgroundPrevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866 · cited 1×
“3 he prevalence of type 2 diabetes increased 61% between 1990 and 2001 (1), and by 2005, it affected nearly 21 million Americans (www.”
BackgroundFollow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543 · cited 3×
“A number of clinical trials have demonstrated the effectiveness of lifestyle and/or drug therapy at preventing diabetes in people with pre-diabetes (2; 4-9), but none have examined the effectiveness of an intervention on returning those with pre-diabetes to NGR.”
BackgroundThe Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 1×
“Insulin sensitivity and secretion are integrally related and the deterioration of each is felt to be requisite in the development of type 2 diabetes (21).”
BackgroundWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“Nevertheless, longitudinal data (22) clearly demonstrate the failure of the -cell as the seminal event in this process.”
BackgroundXENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
(2006) · The Lancet · doi:10.1016/s0140-6736(06)69420-8 · Cited by 1,706 · cited 3×
“A number of clinical trials have demonstrated the effectiveness of lifestyle and/or drug therapy at preventing diabetes in people with pre-diabetes (2; 4-9), but none have examined the effectiveness of an intervention on returning those with pre-diabetes to NGR.”
BackgroundEffect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344
Self-citation
Cited by
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
“3.6 We recommend metformin in women with PCOS who have T2DM or IGT who fail lifestyle modification (1 QQQE).”
BackgroundInfluentialPerreault, L., Pan, Q., Mather, K. J., Watson, K. E., Hamman, R. F., & Kahn, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60525-x · Cited by 532
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Balk, E. M., Earley, A., Raman, G., Avendano, E. A., Pittas, A. G., & Remington, P. L. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0452 · Cited by 371
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
“Lower fasting glucose, weight loss, younger age and higher insulin secretion predicted reversion from IGT to normal glucose tolerance in the DPP [82].”
BackgroundGanz, M. L., Wintfeld, N., Li, Q., Alas, V., Langer, J., & Hammer, M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-50 · Cited by 242
“Additionally, weight loss among subjects in the lifestyle-modification program was significantly and independently associated with reductions in blood glucose from pre-diabetic to normal levels [34].”
Backgroundβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
The oral glucose tolerance test (OGTT) revisited
Bartoli, E., Fra, G. P., & Schianca, G. P. C. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.07.008 · Cited by 219
Ali, M. K., Bullard, K. M., Saydah, S., Imperatore, G., & Gregg, E. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30027-5 · Cited by 208
“Robust randomized controlled trials in multiple countries have shown that intensive LSM (eating fiber rich foods, being physically active, and managing weight) for people with impaired glucose tolerance can slow progression to diabetes,(30, 31) and are associated with numerous other benefits (regression to normoglycem…”
BackgroundPhenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Hivert, M.-F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., Hamman, R. F., Kahn, S. E., Haffner, S., the DIAGRAM Consortium, et al. (2011) · Diabetes · doi:10.2337/db10-1119 · Cited by 191
Self-citationI Diretriz Brasileira de Prevenção Cardiovascular
Simão, A., Precoma, D., Andrade, J., Correa Filho, H., Saraiva, J., Oliveira, G., Murro, A., Campos, A., Alessi, A., Avezum Junior, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s012 · Cited by 178
Bergman, M., Manco, M., Satman, I., Chan, J., Schmidt, M. I., Sesti, G., Vanessa Fiorentino, T., Abdul-Ghani, M., Jagannathan, R., Kumar Thyparambil Aravindakshan, P., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111589 · Cited by 171
Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis
Galaviz, K. I., Weber, M. B., Suvada, K., Gujral, U. P., Wei, J., Merchant, R., Dharanendra, S., Haw, J. S., Narayan, K. M. V., & Ali, M. K. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.10.020 · Cited by 149
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A. S., Imamura, M., Black, C., Boroujerdi, M. A., Jick, S. S., Wyness, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16330 · Cited by 175
Dietary Weight Loss and Exercise Effects on Insulin Resistance in Postmenopausal Women
Mason, C., Foster-Schubert, K. E., Imayama, I., Kong, A., Xiao, L., Bain, C., Campbell, K. L., Wang, C.-Y., Duggan, C. R., Ulrich, C. M., et al. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.042 · Cited by 142
Perreault, L., Temprosa, M., Mather, K. J., Horton, E., Kitabchi, A., Larkin, M., Montez, M. G., Thayer, D., Orchard, T. J., Hamman, R. F., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0656 · Cited by 131
Self-citationBenefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
Kim, S., Abbasi, F., Lamendola, C., Liu, A., Ariel, D., Schaaf, P., Grove, K., Tomasso, V., Ochoa, H., Liu, Y.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0354 · Cited by 100
Perreault, L., Pan, Q., Schroeder, E. B., Kalyani, R. R., Bray, G. A., Dagogo-Jack, S., White, N. H., Goldberg, R. B., Kahn, S. E., Knowler, W. C., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0244 · Cited by 106
Self-citationAntidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Meneses, M. J., Silva, B. M., Sousa, M., Sá, R., Oliveira, P. F., & Alves, M. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710145753 · Cited by 132
Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., Petrie, J. R., & Mingrone, G. (2010) · Diabetes Care · doi:10.2337/dc09-2261 · Cited by 120
Fritsche, A., Wagner, R. J., Heni, M., Kantartzis, K., Machann, J., Schick, F., Lehmann, R., Peter, A., Dannecker, C., Fritsche, L., et al. (2021) · Diabetes · doi:10.2337/db21-0526 · Cited by 112
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Perreault, L., Davies, M., Frias, J. P., Laursen, P. N., Lingvay, I., Machineni, S., Varbo, A., Wilding, J. P. H., Wallenstein, S. O. R., & le Roux, C. W. (2022) · Diabetes Care · doi:10.2337/dc21-1785 · Cited by 87
Self-citationon behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
Madsen, K. S., Chi, Y., Metzendorf, M.-I., Richter, B., & Hemmingsen, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008558.pub2 · Cited by 70
Perreault, L., & Færch, K. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.008 · Cited by 92
Self-citationOne-hour post-load plasma glucose level during the OGTT predicts dysglycemia
Bergman, M., Chetrit, A., Roth, J., Jagannathan, R., Sevick, M. A., & Dankner, R. S. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.08.013 · Cited by 71
Oral glucose tolerance test in diabetes, the old method revisited
Kuo, F. Y., Cheng, K., Li, Y., & Cheng, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.786 · Cited by 70
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
Self-citationRegression from prediabetes to normal glucose regulation: State of the science
Sallar, A. S., & Dagogo-Jack, S. E. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220915644 · Cited by 74
Stefan, N., Staiger, H., Wagner, R. J., Machann, J., Schick, F., Häring, H., & Fritsche, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3760-z · Cited by 65
“Perreault et al also identified lower fasting and 2 h blood glucose levels, younger age and higher insulin secretion as baseline variables predicting a higher chance for regression towards NGR in all three treatment groups combined [13].”
BackgroundHemmingsen, B., Sonne, D. P., Metzendorf, M.-I., & Richter, B. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012151.pub2 · Cited by 60
Andújar-Plata, P., Pi-Sunyer, X., & Laferrère, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.022 · Cited by 69
“Metformin use also predicted regression from impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) to isolated IGT, but not to normal glucose tolerance [22], and improved insulin sensitivity at one year compared with placebo [23].”
BackgroundPrevalence of Major Behavioral Risk Factors for Type 2 Diabetes
Siegel, K. R., Bullard, K. M., Imperatore, G., Ali, M. K., Albright, A. L., Mercado, C. I., Li, R., & Gregg, E. W. (2018) · Diabetes Care · doi:10.2337/dc17-1775 · Cited by 68
Early Response to Preventive Strategies in the Diabetes Prevention Program
Maruthur, N. M., Ma, Y., Delahanty, L. M., Nelson, J. A. E., Aroda, V. R., White, N. H., Marrero, D. G., Brancati, F. L., & Clark, J. M. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2548-4 · Cited by 63
Wang, R., Qiu, X., Pan, R., Fu, H., Zhang, Z., Wang, Q., Chen, H., Wu, Q., Pan, X., Zhou, Y., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211779 · Cited by 61
“…clinical trials have demonstrated the efficacy of lifestyle interventions in delaying or preventing the development of diabetes in people with prediabetes or even at the early stage of T2D (Dagogo-Jack et al., 2020; Eriksson and Lindg¨arde, 1991; Knowler et al., 2002; Perreault et al., 2009).”
Perreault, L., Pan, Q., Aroda, V. R., Barrett-Connor, E., Dabelea, D., Dagogo-Jack, S., Hamman, R. F., Kahn, S. E., Mather, K. J., Knowler, W. C., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13453 · Cited by 55
Self-citationPalmer, A. J., & Tucker, D. M. D. (2012) · Primary Care Diabetes · doi:10.1016/j.pcd.2011.10.006 · Cited by 53
Prediabetes remission to reduce the global burden of type 2 diabetes
Sandforth, L., Kullmann, S., Sandforth, A., Fritsche, A., von Schwartzenberg, R. J., Stefan, N., & Birkenfeld, A. L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.01.004 · Cited by 58
Bergman, M., Jagannathan, R., Buysschaert, M., Pareek, M., Olsen, M. H., Nilsson, P. M., Medina, J. L., Roth, J., Chetrit, A., Groop, L., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2992 · Cited by 56
Lazo-Porras, M., Bernabé‐Ortiz, A., Ruíz-Alejos, A., Smeeth, L. L., Gilman, R. H., Checkley, W., Málaga, G., & Miranda, J. J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107829 · Cited by 56
Haemer, M. A., Grow, H. M., Fernandez, C., Lukasiewicz, G., Rhodes, E. T., Shaffer, L. A., Sweeney, B. R., Woolford, S. J., & Estrada, E. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0158 · Cited by 55
“78 Research studies to inform similar recommendations in youth are needed, especially during critical periods of increased IR, such as puberty.”
Ku, G. M., & Kegels, G. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.07.004 · Cited by 58
Galderisi, A., Giannini, C., Weiss, R., Kim, G. E., Shabanova, V., Santoro, N., Pierpont, B. M., Savoye, M., & Caprio, S. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30235-9 · Cited by 54
“The highly transient nature of IGT, as 65% of our pediatric cohort reverted from IGT to NGT, is in contrast with ~25% of adults with IGT reverting to NGT in the Diabetes Prevention Program (DPP) and in the ACT-NOW cohorts (25, 26) describing, for the first time in pediatrics, the impact of transient dysglycemia on bet…”
BackgroundResultPredictive models for conversion of prediabetes to diabetes
Yokota, N., Miyakoshi, T., Sato, Y., Nakasone, Y., Yamashita, K., Imai, T., Hirabayashi, K., Koike, H., Yamauchi, K., & Aizawa, T. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.005 · Cited by 54
Reversal of Prediabetes in Saudi Adults: Results from an 18 Month Lifestyle Intervention
Amer, O. E., Sabico, S., Alfawaz, H., Aljohani, N., Hussain, S. D., Alnaami, A. M., Wani, K., & Al‐Daghri, N. M. (2020) · Nutrients · doi:10.3390/nu12030804 · Cited by 51
“Additionally, reversion to normoglycemia by lifestyle intervention was seen independently of body weight reduction [28].”
Backgroundβ-Cell Dysfunction Is Associated with Metabolic Syndrome Severity in Adults
Malin, S. K., Finnegan, S., Fealy, C. E., Filion, J., Rocco, M. B., & Kirwan, J. P. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0083 · Cited by 48
“32 Last, it is important to consider the relatively low number of individuals representing different races ( i.e ., African Americans, Hispanic, etc.) in our study.”
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 71
Galderisi, A., Polidori, D., Weiss, R., Giannini, C., Pierpont, B. M., Tricò, D., & Caprio, S. (2019) · Diabetes · doi:10.2337/db19-0120 · Cited by 56
Tura, A., Grespan, E., Göbl, C. S., Koivula, R. W., Franks, P. W., Pearson, E. R., Walker, M., Forgie, I. M., Giordano, G. N., Pavo, I. J., et al. (2021) · Diabetes · doi:10.2337/db21-0227 · Cited by 53
Xu, D.-F., Sun, J.-Q., Chen, M., Chen, Y.-Q., Xie, H., Sun, W.-J., Lin, Y.-F., Jiang, J.-J., Sun, W., Chen, A.-F., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512001328 · Cited by 44
Arreola, E. V., Gong, Q., Hanson, R. L., Wang, J., Sandforth, L., He, S., Sandforth, A., Qian, X., Giacca, M., Bornstein, S. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00295-5 · Cited by 59
Fadini, G. P., Sarangdhar, M., & Avogaro, A. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000475 · Cited by 44
Ku, G. M., & Kegels, G. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005317 · Cited by 55
Halliday, T. M., Davy, B. M., Clark, A. G., Baugh, M. E., Hedrick, V. E., Marinik, E. L., Flack, K. D., Savla, J. T., Winett, S. G., & Winett, R. A. (2014) · Eating Behaviors · doi:10.1016/j.eatbeh.2014.04.004 · Cited by 46
“…sedentary or minimally active (i.e., <120 min/week of moderate intensity physical activity) adults with prediabetes (impaired fasting glucose ≥95 and <126 mg/dl and/or impaired glucose tolerance ≥140 and <200 mg/dl) (Genuth et al., 2003; Knowler et al., 2002; Perreault et al., 2009) were eligible.”
BackgroundSun, Y., Zhang, L., Duan, W., Xin, M., & Jia, C. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12653 · Cited by 45
Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study
McKenzie, A. L., Athinarayanan, S. J., McCue, J. J., Adams, R. N., Keyes, M., McCarter, J. P., Volek, J. S., Phinney, S. D., & Hallberg, S. J. (2021) · Nutrients · doi:10.3390/nu13030749 · Cited by 37
“Lifestyle intervention independent of weight loss predicted regression to normoglycemia in the DPP [32], and hyperglycemia can be resolved prior to significant weight loss following bariatric surgery [33].”
BackgroundSchmid, V., Wagner, R. J., Sailer, C., Fritsche, L., Kantartzis, K., Peter, A., Heni, M., Häring, H., Stefan, N., & Fritsche, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4407-z · Cited by 41
Galderisi, A., Giannini, C., Name, M. A. V., & Caprio, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00161 · Cited by 41
A practical approach to the metabolic syndrome: review of current concepts and management
Tota-Maharaj, R., Defilippis, A. P., Blumenthal, R. S., & Blaha, M. J. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32833cd474 · Cited by 36
Gender-related affecting factors of prediabetes on its 10-year outcome
Song, X., Qiu, M., Zhang, X., Wang, H., Tong, W., Ju, L., Gu, L., Sun, S., Zhang, H., Wang, W., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000169 · Cited by 37
“Although risk factors of developing diabetes are well established,(12) far less is known about factors affecting the transformation from prediabetes to normal glucose regulation.(13) There is a variety of possible contributors, including genetic factors, environmental exposures, physical activity, and metabolic disord…”
BackgroundInfluentialvon Schwartzenberg, R. J., Arreola, E. V., Sandforth, A., Hanson, R. L., & Birkenfeld, A. L. (2024) · Diabetologia · doi:10.1007/s00125-024-06178-5 · Cited by 33
“Previous analysis from the DPP showed that younger age and insulin secretion at baseline were predictive for remission [8].”
BackgroundMethodPrediabetes: To treat or not to treat?
Moutzouri, E., Tsimihodimos, V., Rizos, E. C., & Elisaf, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.007 · Cited by 36
Hulmán, Á., Simmons, R. K., Vistisen, D., Tabák, Á. G., Dekker, J. M., Alssema, M., Rutters, F., Koopman, A. D. M., Solomon, T. P. J., Kirwan, J. P., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1126-z · Cited by 33
Hwang, Y., Cho, I., Jeong, I., Ahn, K. J., & Chung, H. Y. (2018) · Diabetic Medicine · doi:10.1111/dme.13789 · Cited by 34
Food insecurity is associated with prediabetes and dietary differences in U.S. adults aged 20–39
Lee, A. M., Scharf, R. J., & DeBoer, M. D. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.09.012 · Cited by 32
Reframing prediabetes: A call for better risk stratification and intervention
Kim, S. H. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13786 · Cited by 33
Pratte, K., Johnson, A., Beals, J., Bullock, A. K., Manson, S. M., Jiang, L., & Program, A. T. S. D. P. F. I. D. P. (2019) · Diabetes Care · doi:10.2337/dc18-1964 · Cited by 28
Nanditha, A., Jagannathan, R., Snehalatha, C., Selvam, S., Susairaj, P., Shetty, A. S., Raghavan, A., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2014) · Diabetes Care · doi:10.2337/dc14-0407 · Cited by 32
Physical Activity for the Prevention of Cardiometabolic Disease
Bull, F., Goenka, S., Lambert, V., & Pratt, M. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch5 · Cited by 47
Alizadeh, Z., Baradaran, H. R., Kohansal, K., Hadaegh, F., Azizi, F., & Khalili, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1041808 · Cited by 30
“A previous study (12) found an association between female sex and regression to normoglycemia, whereas other studies did not (13, 14).”
ResultInadequacies of current approaches to prediabetes and diabetes prevention
Bergman, M. (2013) · Endocrine · doi:10.1007/s12020-013-0017-9 · Cited by 26
Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria
Færch, K., Witte, D. R., Brunner, E. J., Kivimäki, M., Tabák, Á. G., Jørgensen, M. E., Ekelund, U., & Vistisen, D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00990 · Cited by 27
García de la Torre, N., Durán, A., del Valle, L., Fuentes, M., Barca, I., Martín, P., Montañez, C., Perez-Ferre, N., Abad, R., Sanz, F., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0467-9 · Cited by 24
Hasnain, M., Fredrickson, S. K., & Vieweg, W. V. R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110389214 · Cited by 24
“The observation in the DPP (Kitabchi et al., 2005; Perreault et al., 2009) that insulin secretion and other biological processes retained with younger age were pivotal in restoring normal glucose regulation would also favor an early use of metformin in high-risk individuals.”
BackgroundHan, Y. Y., Hu, H., Huang, Z., & Liu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1111791 · Cited by 26
Bahadoran, Z., Mirmiran, P., Shabani, M., & Azizi, F. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102233 · Cited by 26
Davoodian, N., Lotfaliany, M., Huxley, R., Lee, C., Pasco, J. A., Adams, R., Azizi, F., Bertoni, A. G., Björkelund, C., Colagiuri, S., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00237-2 · Cited by 29
Dagogo-Jack, S. E., UMEKWE, N. A., Brewer, A., Owei, I., Mupparaju, V. K., Rosenthal, R. H., & Wan, J. Y. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002748 · Cited by 25
Sevilla-González, M. D. R., Merino, J., Moreno-Macías, H., Rojas, R., Gómez‐Velasco, D., & Manning, A. K. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01246-1 · Cited by 23
Wang, W., Wei, R., Huang, Z., Luo, J., Pan, Q., & Guo, L. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3680 · Cited by 23
“6,31 Treatment with liraglutide could also improve the glucose ‐ stimulated insulin secretion rate and glucose tolerance.”
Jayedi, A., Soltani, S., Emadi, A., Najafi, A., & Zargar, M. S. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.08.031 · Cited by 21
Staging schema for early diagnosis of prediabetes
Bergman, M., Abdul-Ghani, M. A., Chan, J., Schmidt, M. I., Ha, J., Kim, S. S., Sherman, A., Jagannathan, R., & Tuomilehto, J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00320-6 · Cited by 21
Anderson, J. M. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.08.033 · Cited by 21
Ebenibo, S., Edeoga, C., AMMONS, A., Egbuonu, N., & Dagogo-Jack, S. E. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-64 · Cited by 18
One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes
Abdul‐Ghani, M. A., Abu‐Farha, M., Abdul‐Ghani, T., Chavez-Velazquez, A., Merovci, A., DeFronzo, R. A., Al-Ajmi, F. A., Stern, M. P., & Al‐Mulla, F. (2025) · Diabetes Care · doi:10.2337/dc24-2832 · Cited by 18
Li, N., Lu, C., Ma, Y., Wang, X., Ling, Y., Yin, Y., Li, S., Huang, J., Yu, L., Dong, W., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109193 · Cited by 18
Huang, Z., Han, Y. Y., Hu, H., Cao, C., Liu, D., & Wang, Z. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04752-w · Cited by 20
Liu, L., Guan, X., Yuan, Z., Zhao, M., Li, Q., Zhang, X., Zhang, H., Zheng, D., Xu, J., Gao, L., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4328975 · Cited by 17
“However, previous studies focused on either the identification of risk factors for the deterioration from NGT or prediabetes to overt diabetes [10–13] or the association with the reversion from prediabetes to NGT [14, 15].”
Self-citationRefuerzo, J., Viteri, O. A., Hutchinson, M. S., Pedroza, C., Blackwell, S. C., Tyson, J. E., & Ramin, S. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.12.019 · Cited by 18
Dias, T. R., Bernardino, R. L., Meneses, M. J., Sousa, M., Sá, R., Alves, M. G., Silva, B. M., & Oliveira, P. F. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160229113629 · Cited by 19
Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes
Roncero‐Ramos, I., Jiménez-Lucena, R., Alcala-Diaz, J. F., Vals‐Delgado, C., Larriva, A. P. A.-D., Rangel-Zúñiga, O. A., Leon‐Acuña, A., Malagón, M. M., Delgado‐Lista, J., Pérez‐Martínez, P., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.012 · Cited by 19
On behalf of the NEXT-D Study Group, Ali, M. K., Wharam, J. F., Duru, O. K., Schmittdiel, J. A., Ackermann, R. T., Albu, J., Ross‐Degnan, D., Hunter, C. M., Mangione, C. M., et al. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1112-3 · Cited by 16
Chai, X., Wang, Y., Yin, X., Gong, Q., Zhang, J., Shao, R., & Li, G. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103184 · Cited by 18
Younis, A., Goldkorn, R., Goldenberg, I., Geva, D., Tzur, B., Mazu, A., Younis, A., Fisman, E. Z., Tannenbaum, A., & Klempfner, R. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006609 · Cited by 17
Cuesta, M., Fuentes, M. E., Rubio, M. Á., Bordiú, E., Barabash, A., de la Torre, N. G., Rojo‐Martínez, G., Valdés, S., Soriguer, F., Vendrell, J. J., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001715 · Cited by 20
Is regression to normoglycaemia clinically important?
Yakubovich, N., & Gerstein, H. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60828-9 · Cited by 15
Souto-Gallardo, M. A. C., Bacardí‐Gascón, M., & Cruz, A. J. (2011) · PubMed · doi:10.1590/s0212-16112011000600008 · Cited by 21
Guideline for the Management of Insulin Resistance
Govers, E. (2015) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.115 · Cited by 18
“Physical activity leads to diminishing of IR [40-44].”
Background
Metadata
- Authors
- Perreault, L., Kahn, S. E., Christophi, C. A., Knowler, W. C., Hamman, R. F., & the Diabetes Prevention Program Research Group
- Affiliations
- University of Colorado Anschutz (US)
- University of Washington (US)
- George Washington University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Colorado School of Public Health (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-07-08
- Volume
- 32
- Issue
- 9
- Pages
- 1583-1588
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2732165
- OpenAlex
- W2109748090
- Cited by
- 209
- References
- 25
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 19 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 14 · 2019: 12 · 2018: 15 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 14 · 2012: 9
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, Diabetes Prevention Program, intensive lifestyle intervention, metformin, weight loss, insulin secretion, insulin sensitivity, impaired fasting glucose, impaired glucose tolerance
- MeSH terms
- Insulin Secretion, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Insulin, Life Style, Male, Metformin, Middle Aged, Prediabetic State, Sex Factors, Weight Loss, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.